Liquid biopsy: New frontier in small-cell lung cancer management

“Reporting in Science Advances, scientists at the Fred Hutchinson Cancer Center in Seattle have presented a blood-based test, known as liquid biopsy, capable of accurately distinguishing between types and subtypes of small cell lung cancer (SCLC), offering hope for precise diagnosis and personalized treatment plans for patients. . . . .  Differentiating lung cancer types using the test works through examination of patterns within cell-free DNA, offering insights into tumor biology without the need for invasive procedures. A feature that is particularly important for SCLC, characterized by many smaller tumors and a variety of subtypes, each requiring a different treatment strategy.”     MORE

Image Credit- InsidePrecisionMedicine,  Shubhangi Ganeshrao Kene, Science Photo Library, Getty